AARD
Aardvark Therapeutics Inc (AARD)
Healthcare • NASDAQ • $5.44-2.86%
Key Fundamentals
- Symbol
- AARD
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Biotechnology
- Price
- $5.44
- Daily Change
- -2.86%
- Market Cap
- $118.68M
- Trailing P/E
- N/A
- Forward P/E
- -1.66
- 52W High
- $17.94
- 52W Low
- $3.35
- Analyst Target
- $16.70
- Dividend Yield
- N/A
- Beta
- N/A
About Aardvark Therapeutics Inc
Aardvark Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. Aardvark Therapeutics, Inc. was incorporated in 2017 and is headquartered in San Diego, California.
Company websiteResearch AARD on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.